Kangmei Pharmaceutical announced on August 21 that the board of directors of the company recently received a written resignation report submitted by Mr. Lai Zhijian, the chairman of the company. Due to job adjustments, Lai Zhijian resigned as chairman and director of the company, no longer serves as the company's legal representative, and also resigned as a member of the Audit Committee of the Board of Directors and the convener of the Strategy Committee. After resigning, Lai Chi-kin will no longer hold any position in the company. Since the election of the new chairman of the company still needs to go through corresponding legal procedures, in order to ensure the good operation of the company's board of directors and the smooth development of management decisions, the company held the 5th interim meeting of the 10th board of directors in 2026 to review and pass the “Proposal on Nominating Directors to Act as Chairman and Legal Representative”. The board of directors nominated Ou Guoxiong, the company's director and general manager to perform the duties of chairman and legal representative on behalf of the company, and authorized Ou Guoxiong to sign relevant documents on behalf of the company. The term of acting for the above mentioned period starts from the date of review and approval by the board of directors and ends on the date the board of directors elects a new chairman.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.